Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Koninklijke Philips N.V. (NYSE: PHG) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Koninklijke Philips N.V. (NYSE: PHG) concerning whether a series of statements by Koninklijke Philips N.V. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 11, 2017, Koninklijke Philips revealed that following discussions with the U.S. Department of Justice, the Company is temporarily suspending production of defibrillators for the U.S. market, in order to allow closer inspections and ensure that Koninklijke Philips is in compliance with applicable U.S. Food and Drug Administration regulations.  The Company advised investors that the production halt would likely last until the third quarter of 2018 and could cut earnings before interest and taxes by some 20 million euros ($24 million) in the final quarter of 2017, and by a further 60 million euros in 2018. 

Following this news, NYSE: PHG fell during intraday trading on October 11, 2017.

Based in Amsterdam, the Netherlands, and founded in 1891 Koninklijke Philips N.V. operates as a health technology company worldwide.

If you purchased shares of Koninklijke Philips N.V. (NYSE: PHG) on or before October 11, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185